Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Intraductal, Noninfiltrating × Fulvestrant × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 27 Ovarian Neoplasms 7 Neoplasms 6 Neoplasm Metastasis 6 Endometrial Neoplasms 6 Uterine Cervical Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Prostatic Neoplasms 3 Neoplasms by Site 3 Breast Diseases 3 Triple Negative Breast Neoplasms 2 Hereditary Sensory and Autonomic Neuropathies 2 Head and Neck Neoplasms 2 Uterine Neoplasms 1 Urogenital Neoplasms 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Recurrence 1 Melanoma 1 Malignant Neoplasms of Female Genital Organs 1 Lung Neoplasms 1 Locoregional Recurrence 1 HR+/HER2- Breast Cancer 1 HER2-positive Metastatic Breast Cancer 1 Genital Neoplasms, Female 1 Fallopian Tube Neoplasms 1 Exanthema 1 Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer 1 Esophageal Squamous Cell Carcinoma 1

Interventions

Tamoxifen 6 Specimen Handling 4 exemestane 3 Letrozole 3 Anastrozole 3 Biopsy 2 poly ICLC 1 fezolinetant 1 elacestrant 1 Testosterone 1 Surveys and Questionnaires 1 Selective Estrogen Receptor Modulators 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Radiation Dose Hypofractionation 1 Radiation 1 Neoadjuvant Therapy 1 Multicenter Studies as Topic 1 Medicare 1 Mastectomy, Segmental 1 Mastectomy 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Diet Records 1 Colony-Stimulating Factors 1 CD2-associated protein 1 Blood Specimen Collection 1 Aromatase Inhibitors 1 4-hydroxy-N-desmethyltamoxifen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡